Brief: AcuCort Signs Agreement With CRO Quinta-Analytica
21/06/2018 09:43
June 21 (Reuters) - AcuCort AB ACUC.TE :
* ACUCORT SIGNS AGREEMENT WITH THE CRO QUINTA-ANALYTICA
CONCERNING
THE PERFORMANCE OF BIOEQUIVALENCE STUDIES
* BIOEQUIVALENCE STUDIES ARE PLANNED TO START DURING SECOND
HALF
OF 2018
Source text: https://bit.ly/2trIIAJ
Further company coverage: ACUC.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA